0.044
0.00 (-2.22%)
| Previous Close | 0.045 |
| Open | 0.044 |
| Volume | 4,115,800 |
| Avg. Volume (3M) | 2,870,781 |
| Market Cap | 1,163,408,384 |
| Price / Earnings (Forward) | 50.00 |
| Price / Sales | 3.19 |
| Price / Book | 2.38 |
| 52 Weeks Range | |
| Earnings Date | 17 Feb 2025 |
| Profit Margin | 0.13% |
| Operating Margin (TTM) | 9.99% |
| Quarterly Revenue Growth (YOY) | 18.00% |
| Quarterly Earnings Growth (YOY) | -2.50% |
| Total Debt/Equity (MRQ) | 188.92% |
| Current Ratio (MRQ) | 0.870 |
| Operating Cash Flow (TTM) | -20.46 M |
| Levered Free Cash Flow (TTM) | -120.28 M |
| Return on Assets (TTM) | 1.42% |
| Return on Equity (TTM) | 0.34% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (SG) | Mixed | Bearish |
| Medical Care Facilities (Global) | Bearish | Mixed | |
| Stock | Thomson Medical | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | 1.0 |
| Insider Activity | NA |
| Price Volatility | 1.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 2.0 |
| Average | 1.13 |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| THOMSON MEDICAL | 1 B | - | - | 2.38 |
| RAFFLES MEDICAL | 2 B | 2.45% | 32.67 | 1.75 |
| IHH | 19 B | 4.81% | 23.78 | 2.02 |
| TALKMED | 592 M | 8.09% | 14.83 | 7.02 |
| Q&M DENTAL | 280 M | 3.73% | 14.75 | 2.64 |
| ISEC | 190 M | 3.49% | 16.50 | 2.43 |
|
Thomson Medical Group Ltd is a provider of healthcare services for women and children. Its segments include Hospital services; Specialised services and Investment holdings. It generates maximum revenue from the Specialised services segment. The specialised services segment includes services provided by fertility clinics, paediatric centres, cancer centre, cardiology centre, Chinese medicine, specialist skin centre and a pre-natal and clinical diagnostic laboratory and project-related services such as managing vaccination centres, COVID-19 Treatment Facilities and Transitional Care Facilities. It also includes a consumer business segment, comprising products and services. Geographically, it derives a majority of its revenue from Singapore. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Mid Core |
| % Held by Insiders | 90.03% |
| % Held by Institutions | 0.08% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Lim (Eng Hock) | 13 Sep 2024 | 23,725,309,427 (89.73%) |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 0.050 (Maybank Research, 13.64%) | Buy |
| Median | 0.049 (11.36%) | |
| Low | 0.048 (Phillip Securities, 9.09%) | Hold |
| Average | 0.049 (11.36%) | |
| Total | 1 Buy, 1 Hold | |
| Avg. Price @ Call | 0.045 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Phillip Securities | 18 Feb 2025 | 0.048 (9.09%) | Hold | 0.045 |
| Maybank Research | 13 Feb 2025 | 0.050 (13.64%) | Buy | 0.045 |
No data within this time range.
| 5Y Average Dividend Yield | 0.46% |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 24 Oct 2023 | 26 Sep 2023 | 03 Nov 2023 | 0.0004 Cash |
| 07 Nov 2022 | 14 Oct 2022 | 17 Nov 2022 | 0.00115 Cash |
| 02 Nov 2021 | 11 Oct 2021 | 12 Nov 2021 | 0.00015 Cash |
| 14 May 2019 | 01 Mar 2019 | 28 May 2019 | 0.00025 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2023 | 0.000 | 1 | 0.66 |
| 2022 | 0.001 | 1 | 1.47 |
| 2021 | 0.000 | 1 | 0.18 |
| 2019 | 0.000 | 1 | 0.39 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |